Delivery Order SPE2DR25D3301-SPE2DR26F21RG
- Not listed
- The Defense Logistics Agency awarded a $1,127.75 delivery order to AmerisourceBergen Drug Corp for the supply of Ultane 250 milliliter pen bottles on January 30, 2026, with an ultimate completion date of February 2, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial...
- The Defense Logistics Agency awarded a $1,443.90 delivery order to AmerisourceBergen Drug Corp for 250 ml of Ultane in a pen bottle configuration, with an ultimate completion date of October 17, 2025. This is a firm fixed price, competitively awarded order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,398.41 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML pen bottles on January 27, 2026, with an ultimate completion date of January 28, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,012.42 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML in pen bottle format, with delivery to be completed by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply chain...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 17, 2025, for the supply of Ultane 250 ML pen bottles. This non-set-aside contract is valued at $1,537.80 and is classified as a firm fixed price delivery order with an ultimate completion date of November 18, 2025. The award supports federal medical procurement needs, with performance occurring at the contractor's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order valued at $1,155.12 by the Defense Logistics Agency (DLA) for Ultane 250 ml in pen bottle format. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and was competitively awarded without a set-aside designation. This award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 250 mL of Ultane in a pen bottle configuration, valued at $2,596.98. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 12, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a $1,299.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Ultane in pen bottle format, with a completion date of August 22, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place of performance. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ultane 250 milliliter pen bottles, with a ceiling value of $1,071.80 and a firm fixed price structure. The contract, awarded on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a non-set-aside competitive award. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21RGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,263.08 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML pen bottles on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price contract, which is not set-aside, will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The company was competitively selected through open competition and maintains an extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting demonstrates versatility across multiple therapeutic domains and order values, positioning it as a key provider of essential medical commodities to support military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/1/26 |